A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular Disease

  Рет қаралды 9,008

Emory Cardiology

Emory Cardiology

2 жыл бұрын

Emory Cardiology GrandRounds 04-11-2022
Speaker: Dan Sorescu, MD, FACC

Пікірлер
Professor Milton Packer - 'Heart failure - are there limits to anti-diabetic therapy with SGLT2'
38:55
At the Limits - Leading Medical Education
Рет қаралды 14 М.
Scary Teacher 3D Nick Troll Squid Game in Brush Teeth White or Black Challenge #shorts
00:47
아이스크림으로 체감되는 요즘 물가
00:16
진영민yeongmin
Рет қаралды 60 МЛН
Diabetes and the Heart. ESC Guidelines: Part 1
19:19
Cardio Buzz
Рет қаралды 5 М.
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'
35:24
At the Limits - Leading Medical Education
Рет қаралды 29 М.
How SGLT2 Inhibitors Protect The Kidney
16:24
Conan Liu, M.D.
Рет қаралды 14 М.
What are SGLT2 inhibitors and how do they affect kidney disease?
10:55
Plant Based Kidney Health
Рет қаралды 10 М.
Best Practices for Starting SGLT2 Inhibitors in HFpEF Treatment
10:57
A tale of sugar, fat and salt Emory University part 1
1:05:54
Dan Sorescu
Рет қаралды 661
Updates in Treatment Pathways for Patients with Heart Failure
1:09:43
Emory Cardiology
Рет қаралды 18 М.
Using SGLT2-inhibitors to treat cardiac patients with diabetes
13:49
Ted Rogers Centre for Heart Research
Рет қаралды 33 М.
Diastolic Function
1:03:26
Emory Cardiology
Рет қаралды 8 М.
Scary Teacher 3D Nick Troll Squid Game in Brush Teeth White or Black Challenge #shorts
00:47